Memantin Aurobindo (Memantine Hydrochloride)

Memantine hydrochloride is an uncompetitive antagonist of the NMDA receptor. It blocks excessive calcium influx through the receptor’s ion channel only when the channel is over‑activated, thereby reducing excitotoxic neuronal damage that contributes to cognitive decline in Alzheimer’s disease.

The appropriate dose of Memantin Aurobindo is determined by the prescribing clinician based on the patient’s condition, age, renal function and other factors. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for memantine in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantin Aurobindo belongs to the NMDA receptor antagonist class, whereas many other Alzheimer’s agents are cholinesterase inhibitors. Memantine works by reducing excitotoxicity, while cholinesterase inhibitors increase acetylcholine levels. The choice of therapy depends on disease stage, patient tolerance and physician judgment.

Store Memantin Aurobindo at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Memantin Aurobindo is taken orally, usually as a tablet. It should be swallowed with water and may be taken with or without food, following the dosing schedule prescribed by the healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis, rare skin conditions like Stevens‑Johnson syndrome, seizures, hallucinations, cardiac arrhythmias and potential liver injury. Patients should seek immediate medical attention if any of these symptoms occur.

Memantin Aurobindo should be avoided in patients with known hypersensitivity to memantine or any excipients, in those taking other NMDA antagonists that could cause additive toxicity, and in individuals with uncontrolled severe renal impairment unless dose adjustments are made under medical supervision.